Dr Yu discusses the ARCAD Nomogram in a Real-World CRC Population

James Yu, MD, discusses the validation of the ARCAD nomogram in the real-world setting for patients with stage IV colorectal cancer.

Related Keywords

Australia ,Australian ,James Yu ,Moffitt Cancer Center ,Colorectal Cancer ,